168 related articles for article (PubMed ID: 21611837)
21. Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization: evidence of distinct clonal origin.
Chang H; Wechalekar A; Li L; Reece D
Cancer Genet Cytogenet; 2004 Jan; 148(1):44-8. PubMed ID: 14697640
[TBL] [Abstract][Full Text] [Related]
22. [Study on molecular cytogenetic abnormalities in multiple myeloma].
Liu SY; Li JY; Chen LJ; Huang JW; Pan JL; Qiu HR; Shen YF; Xu W; Xue YQ
Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):223-6. PubMed ID: 17877196
[TBL] [Abstract][Full Text] [Related]
23. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
[TBL] [Abstract][Full Text] [Related]
24. [Application of CD138 Immunomagnetic Bead Sorting Combined with Fluorescence in Situ Hybridization in Multiple Myeloma].
Li QZ; Tan K; Liu YX; Huang H; Zhang Y; Chen HM; Chen ZZ; Zhu ZW; Yang BH; Hu GY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1496-1500. PubMed ID: 36208255
[TBL] [Abstract][Full Text] [Related]
25. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
Alpar D; de Jong D; Holczer-Nagy Z; Kajtar B; Savola S; Jakso P; David M; Kosztolanyi S; Kereskai L; Pajor L; Szuhai K
Genes Chromosomes Cancer; 2013 Sep; 52(9):785-93. PubMed ID: 23720363
[TBL] [Abstract][Full Text] [Related]
26. [Retrospective Analysis of Genetics Abnormalities in Patients with Multiple Myeloma].
Wang CB; Wu J; Yang K; Su M; Zhang HY; Pan YZ; Wu T; Xi R; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1681-1687. PubMed ID: 30501704
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of chromosomal abnormalities detected by interphase fluorescence in situ hybridization in newly diagnosed multiple myeloma patients.
Hu Y; Chen L; Sun CY; She XM; Ai LS; Qin Y
Chin Med J (Engl); 2011 Oct; 124(19):2981-5. PubMed ID: 22040539
[TBL] [Abstract][Full Text] [Related]
28. [Cytogenetic study on 53 patients with multiple myeloma].
Jing Y; Fang MY; Jiang F; Lin S; Wang FT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):68-72. PubMed ID: 21362224
[TBL] [Abstract][Full Text] [Related]
29. [Cytogenetic abnormality of chromosome 13q14 in 112 patients with multiple myeloma detected by using LSI-RB1 and LSI-D13S319 probes].
Li F; Hu LP; An G; Xu Y; Wang YY; Xing LJ; Yi SH; Xie ZQ; Qiu LG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):917-21. PubMed ID: 22931654
[TBL] [Abstract][Full Text] [Related]
30. [Detection of the Cytogenetic Aberrations in Multiple Myeloma by Using Microrray Comparative Genomic Hybridization].
Wang YF; Wang H; Xi LY; Zhang ZH; Wang J; Dong F; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1389-1395. PubMed ID: 30295256
[TBL] [Abstract][Full Text] [Related]
31. Molecular cytogenetic aberrations in Tunisian patients with multiple myeloma identified by cIg-FISH in fixed bone marrow cells.
Gmidène A; Avet-Loiseau H; Sennana H; Ben Abdallah I; Khlif A; Meddeb B; Elloumi M; Saad A
Cytogenet Genome Res; 2012; 136(1):44-9. PubMed ID: 22188899
[TBL] [Abstract][Full Text] [Related]
32. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias.
Sáez B; Martín-Subero JI; Odero MD; Prosper F; Cigudosa JC; Schoch R; Calasanz MJ; Siebert R
Oncol Rep; 2007 Nov; 18(5):1099-106. PubMed ID: 17914559
[TBL] [Abstract][Full Text] [Related]
33. [Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].
Lee JW; Lee JK; Hong YJ; Hong SI; Chang YH
Korean J Lab Med; 2008 Dec; 28(6):413-8. PubMed ID: 19127104
[TBL] [Abstract][Full Text] [Related]
34. Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation.
Greslikova H; Zaoralova R; Filkova H; Nemec P; Oltova A; Kupska R; Rudolecka P; Smetana J; Pour L; Zahradova L; Krejci M; Buchler T; Adam Z; Hajek R; Kuglik P
Neoplasma; 2010; 57(2):111-7. PubMed ID: 20099973
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic characterisation in Chinese patients with chronic lymphocytic leukemia: a prospective, multicenter study on 143 cases analysed with interphase fluorescence in situ hybridisation.
Qiu HX; Xu W; Cao XS; Zhou M; Shen YF; Xu YL; Sun XM; Liu Q; Wang R; Qiu HR; Wang JS; Li JY
Leuk Lymphoma; 2008 Oct; 49(10):1887-92. PubMed ID: 18949612
[TBL] [Abstract][Full Text] [Related]
36. [Detection of chromosomal aberrations in multiple myeloma with fluorescence in situ hybridization].
Cao P; Chen F; Cheng Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 37(10):983-9. PubMed ID: 23117450
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India.
Govindasamy P; Pandurangan P; Tarigopula A; Mani R; R Samuel C
Asian Pac J Cancer Prev; 2019 Jan; 20(1):235-241. PubMed ID: 30678438
[TBL] [Abstract][Full Text] [Related]
38. [The comparison of three cytogenetic methods for detecting multiple myeloma].
Ren J; Yang LH; Li GX; Fan JL; Hou J
Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):737-40. PubMed ID: 20079209
[TBL] [Abstract][Full Text] [Related]
39. Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group.
Grzasko N; Hajek R; Hus M; Chocholska S; Morawska M; Giannopoulos K; Czarnocki K; Druzd-Sitek A; Pienkowska-Grela B; Rygier J; Usnarska-Zubkiewicz L; Dytfeld D; Kubicki T; Jurczyszyn A; Korpysz M; Dmoszynska A
Leuk Lymphoma; 2017 Sep; 58(9):1-15. PubMed ID: 28092996
[TBL] [Abstract][Full Text] [Related]
40. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization.
Finelli P; Fabris S; Zagano S; Baldini L; Intini D; Nobili L; Lombardi L; Maiolo AT; Neri A
Blood; 1999 Jul; 94(2):724-32. PubMed ID: 10397739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
